Vimarsana
Biggest News Aggregation in the World

Trial In Progress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial In Progress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial In Progress Today - Breaking & Trending Today

Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at ... - Vimarsana News

Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at ...

Published: October 4, 2023

WALTHAM, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant

Source: eagletribune.com
Related Topics:
United StatesSan DiegoCaitlin LowieFosun PharmaLaura WilliamsKimia KeshtbodArdelyx IncAmerican Society For Pediatric GastroenterologyDrug AdministrationAmerican SocietyPediatric GastroenterologyAnnual MeetingTrial In ProgressPlacebo Controlled StudyPediatric PatientsR Ally PhasePreliminary Blinded Safety DataSerious DehydrationPrescribing InformationBoxed WarningIrritable Bowel SyndromeKyowa KirinKnight TherapeuticsMedia Contacts
Biomea Fusion to Present New Preclinical Data Showing BMF-219's Strong Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Tumor Models at ASCO 2022 Seite 1 - Vimarsana News

Biomea Fusion to Present New Preclinical Data Showing BMF-219's Strong Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Tumor Models at ASCO 2022 Seite 1

Published: May 26, 2022

27.05.2022 - BMF-219 is the first investigational menin inhibitor in clinical development to show potential as a therapeutic agent for CLLBMF-219, a covalent menin inhibitor, demonstrated potency across ex vivo CLL tumor models with varying cytogenetic risk ... Seite 1

Source: wallstreet-online.de
Related Topics:
United StatesThomas ButlerAmerican Society Of Clinical OncologyBiomea Fusion IncAmerican SocietyClinical OncologyAnnual MeetingTrial In ProgressChief Executive Officer